Darmstadt, Germany, October 23, 2017 — Merck, a leading science and technology company, has recognized a group of outstanding postgraduate students for their research and innovations in life science at an awards ceremony at the company’s new Life Science Center in Burlington, Boston, USA.
Twelve student finalists from across the globe (four in each of the three awards categories: bioseparations, 3D printing and food and beverage safety) presented their research to an audience of Merck leaders and guests. Steffen Zobel-Roos, Alexandra Rutz and Ruben R.G. Soares were each named winners of the $10,000 grand prize in their respective categories.
“We are privileged to play a small role in advancing science and technology through these awards,” said Udit Batra, Member of the Merck Executive Board and CEO, Life Science. “I congratulate all of the winners on their projects. Their talents and imagination are already making an important contribution to the next generation of problem solvers.”
In its third year, this international awards competition recognizes postgraduate students from universities in the U.S., Canada and Europe who demonstrate outstanding achievement, skill and commitment to excellence in the life science field through innovative, cutting-edge research. Previously open only to students researching bioseparations, the competition was expanded in 2017 to include awards categories for 3D printing and food and beverage safety. Winning projects in each category were chosen based on level of innovation, impact on the industry, scientific rigor and communication.
Following are the grand prize winners and their research topics:
Other finalists and winners $1,500 prizes were:
Food and Beverage Safety:
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of €16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science and EMD Performance Materials.